| 2023 | A selective ER-phagy exerts neuroprotective effects via modulation of α-synuclein clearance in parkinsonian models | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA |
| 2013 | Changes in the blood–brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: A longitudinal study | PARKINSONISM & RELATED DISORDERS |
| 2025 | DPP-4 inhibitor alleviates gut-brain axis pathology in Parkinson's disease | GUT |
| 2026 | Drug repurposing for disease-modifying effects in multiple system atrophy
| TRANSLATIONAL NEURODEGENERATION |
| 2012 | Elevated homocysteine by levodopa is detrimental to neurogenesis in parkinsonian model
| PLOS ONE |
| 2024 | Energy Transfer Between i-Motif DNA Encapsulated Silver Nanoclusters and Fluorescein Amidite Efficiently Visualizes the Redox State of Live Cells | SMALL |
| 2020 | Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease | JOURNAL OF ALZHEIMERS DISEASE |
| 2021 | Memantine exerts neuroprotective effects by modulating alpha-synuclein transmission in a parkinsonian model | Experimental Neurology |
| 2014 | Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models | AUTOPHAGY |
| 2025 | Mesenchymal stem cells enhance selective ER-phagy to promote α-synuclein clearance in Parkinson's disease
| STEM CELLS TRANSLATIONAL MEDICINE |
| 2020 | Mesenchymal stem cells modulate misfolded alpha-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy | STEM CELL RESEARCH |
| 2017 | Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α-Synuclein in Parkinsonian Models | STEM CELLS |
| 2015 | Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes
| STEM CELL RESEARCH & THERAPY |
| 2009 | Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. | JOURNAL OF NEUROCHEMISTRY |
| 2014 | Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model | NEUROBIOLOGY OF AGING |
| 2025 | Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson's disease
| CELL |
| 2021 | Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models | JOURNAL OF TISSUE ENGINEERING |
| 2022 | Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models | Stem Cell Research and Therapy |
| 2022 | Uric Acid Enhances Neurogenesis in a Parkinsonian Model by Remodeling Mitochondria | Frontiers in Aging Neuroscience |
| 2023 | Uric acid regulates a-synuclein transmission in Parkinsonian models | FRONTIERS IN AGING NEUROSCIENCE |
| 2013 | α-Synuclein pathology is related to postoperative delirium in patients undergoing gastrectomy | NEUROLOGY |
